Pathogenesis of ovarian cancer: clues from selected overexpressed genes.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Future Oncology

• Publication date

  2009-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/fon.09.126PMID 20001801PMCID PMC2821471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE CELL OF ORIGIN OF OVARIAN EPITHELIAL TUMORS

  2014cited by this paper
• A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo

  2010cited by this paper
• Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers*S

  2009cited by this paper
• New therapeutic agents in ovarian cancer

  2009cited by this paper
• Beyond chemotherapy: targeted therapies in ovarian cancer

  2009cited by this paper
• Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53

  2009cited by this paper
• Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours

  2009cited by this paper
• The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms.

  2009cited by this paper
• Ovarian cancer.

  2009cited by this paper
• A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity

  2009cited by this paper
• Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt‐mediated HIF‐1α up‐regulation and MMP9 activation

  2009cited by this paper
• Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer.

  2009cited by this paper
• NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway

  2009cited by this paper
• Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells.

  2009cited by this paper
• Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells

  2009cited by this paper
• Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients

  2009cited by this paper
• MUC4 involvement in ErbB2/ErbB3 phosphorylation and signaling in response to airway cell mechanical injury

  2009cited by this paper
• Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.

  2009cited by this paper
• Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.

  2009cited by this paper
• Osteopontin promotes ovarian cancer progression and cell survival and increases HIF‐1α expression through the PI3‐K/Akt pathway

  2008cited by this paper
• Diagnostic Markers for Early Detection of Ovarian Cancer

  2008cited by this paper
• Diagnostic markers for early detection of ovarian cancer (Clinical Cancer Research (2008) 14, (1065-1072))

  2008cited by this paper
• Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.

  2008cited by this paper
• MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells

  2008cited by this paper
• A BTB/POZ Gene, NAC-1, a Tumor Recurrence–Associated Gene, as a Potential Target for Taxol Resistance in Ovarian Cancer

  2008cited by this paper
• National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.

  2008cited by this paper
• Mesothelin Promotes Anchorage-Independent Growth and Prevents Anoikis via Extracellular Signal-Regulated Kinase Signaling Pathway in Human Breast Cancer Cells

  2008cited by this paper
• Folate receptor alpha as a tumor target in epithelial ovarian cancer.

  2008cited by this paper
• MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells.

  2008cited by this paper
• Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.

  2008cited by this paper
• Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung Tumors

  2008cited by this paper
• BEN: a novel domain in chromatin factors and DNA viral proteins

  2008cited by this paper
• The cell of origin of ovarian epithelial tumours.

  2008cited by this paper
• Fatty acid synthase inhibition results in a magnetic resonance–detectable drop in phosphocholine

  2008cited by this paper
• Notch signaling, gamma-secretase inhibitors, and cancer therapy.

  2007cited by this paper
• Integrating cell-signalling pathways with NF-κB and IKK function

  2007cited by this paper
• Clinical and biological significance of HLA-G expression in ovarian cancer.

  2007cited by this paper
• Integrating cell-signalling pathways with NF-kappaB and IKK function.

  2007cited by this paper
• Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions.

  2007cited by this paper
• Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

  2007cited by this paper
• Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes.

  2007cited by this paper
• Notch Signaling, γ-Secretase Inhibitors, and Cancer Therapy: Figure 1.

  2007cited by this paper
• Amplicon profiles in ovarian serous carcinomas

  2007cited by this paper
• MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells

  2007cited by this paper
• Suppressor Transcription of Gadd 45 GIP 1 , a Candidate Tumor NAC-1 Controls Cell Growth and Survival by Repressing

  2007cited by this paper
• Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.

  2007cited by this paper
• Notch Signaling, ;-Secretase Inhibitors, and Cancer Therapy

  2007cited by this paper
• Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.

  2007cited by this paper
• Ovarian cancer specific kallikrein profile in effusions.

  2007cited by this paper
• MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.

  2007cited by this paper
• Fatty acid synthase and cancer: new application of an old pathway.

  2006cited by this paper
• Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression

  2006cited by this paper
• Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway

  2006cited by this paper
• Notch3 gene amplification in ovarian cancer.

  2006cited by this paper
• Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.

  2006cited by this paper
• Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma

  2006cited by this paper
• A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

  2006cited by this paper
• Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma

  2006cited by this paper
• Proteins Associated with Cisplatin Resistance in Ovarian Cancer Cells Identified by Quantitative Proteomic Technology and Integrated with mRNA Expression Levels*S

  2006cited by this paper
• Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells.

  2006cited by this paper
• Nucleus accumbens neurons are innately tuned for rewarding and aversive taste stimuli, encode their predictors, and are linked to motor output.

  2005cited by this paper
• Claudin proteins in human cancer: promising new targets for diagnosis and therapy.

  2005cited by this paper
• BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.

  2005cited by this paper
• Human tissue kallikrein gene family: applications in cancer.

  2005cited by this paper
• HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.

  2005cited by this paper
• Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.

  2005cited by this paper
• Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells

  2005cited by this paper
• Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma.

  2005cited by this paper
• Humoral Immune Response to Mesothelin in Mesothelioma and Ovarian Cancer Patients

  2005cited by this paper
• Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions.

  2005cited by this paper
• Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression*

  2005cited by this paper
• Apolipoprotein E is required for cell proliferation and survival in ovarian cancer.

  2005cited by this paper
• Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity.

  2005cited by this paper
• Potential markers that complement expression of CA125 in epithelial ovarian cancer.

  2005cited by this paper
• Inhibition of Inhibitor of Nuclear Factor-κB Phosphorylation Increases the Efficacy of Paclitaxel in in Vitro and in Vivo Ovarian Cancer Models

  2004cited by this paper
• Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

  2004cited by this paper
• The emerging roles of human tissue kallikreins in cancer

  2004cited by this paper
• Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer.

  2004cited by this paper
• Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis

  2004cited by this paper
• Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

  2004cited by this paper
• Vascular Endothelial Growth Factor in Predicting Outcome in Breast Cancer

  2004cited by this paper
• Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

  2004cited by this paper
• Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients

  2004cited by this paper
• Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion*

  2004cited by this paper
• Human kallikrein 13 involvement in extracellular matrix degradation.

  2004cited by this paper
• Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.

  2004cited by this paper
• Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models*

  2004cited by this paper
• Mesothelin

  2004cited by this paper
• Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.

  2003cited by this paper
• HLA-G is a potential tumor marker in malignant ascites.

  2003cited by this paper
• Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents

  2003cited by this paper
• Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.

  2003cited by this paper
• Application of Mesothelin Immunostaining in Tumor Diagnosis

  2003cited by this paper
• Detection of HLA-G5 secreting cells.

  2003cited by this paper
• The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma

  2003cited by this paper
• Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.

  2003cited by this paper
• Tumor markers. Physiology, pathobiology, technology, and clinical applications

  2003cited by this paper
• Gene expression patterns in ovarian carcinomas.

  2003cited by this paper
• The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

  2003cited by this paper
• Functional Analysis of the Subunits of the Chromatin Assembly Factor RSF

  2003cited by this paper

• Nanotherapeutics to Overcome Chemotherapy Resistance in Ovarian Cancer.

  2026cites this paper
• Targeting of tumoral NAC1 mitigates myeloid-derived suppressor cell-mediated immunosuppression and potentiates anti-PD-1 therapy in ovarian cancer.

  2024cites this paper
• Lactate activates CCL18 expression via H3K18 lactylation in macrophages to promote tumorigenesis of ovarian cancer

  2024cites this paper
• Human leukocyte antigen‐G in gynaecological tumours

  2023cites this paper
• Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?

  2022cites this paper
• Ovarian cancer health politics in Romania and Germany: A comparative study.

  2021cites this paper
• Glutathione as Oxidative Stress Marker in Cancer

  2021cites this paper
• Prognostic Significance of the MAD1L1 1673 G: A Polymorphism in Ovarian Adenocarcinomas.

  2020cites this paper
• Differential Expression Pattern of Epithelial Mesenchymal Transition Gens: AXL, GAS6, Claudin-1, and Cofilin-1, in Different Stages of Epithelial Ovarian Cancer

  2019cites this paper
• Differential Mechanism of Action of 3,4’,7-O-trimethylquercetin in Three Types of Ovarian Cancer Cells

  2018cites this paper
• Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.

  2018cites this paper
• NACC1, as a Target of MicroRNA-331-3p, Regulates Cell Proliferation in Urothelial Carcinoma Cells

  2018cites this paper
• Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer

  2017cites this paper
• Role of Amylase in Ovarian Cancer

  2017influential citation
• Relevance of HLA-DP/DQ and ICAM-1 SNPs among Ovarian Cancer Patients

  2016cites this paper
• miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6

  2016cites this paper
• Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Müllerian origin, and primary lung adenocarcinoma

  2016cites this paper
• Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.

  2016cites this paper
• Original Article Prognostic value of rsf-1/hbxap in human solid tumors: a meta-analysis of cohort studies

  2015cites this paper
• Prognostic value of rsf-1/hbxap in human solid tumors: a meta-analysis of cohort studies.

  2015cites this paper
• Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers

  2015cites this paper
• Knockdown of STAT3 expression in SKOV3 cells by biodegradable siRNA-PLGA/CSO conjugate micelles.

  2015cites this paper
• The Therapeutic Targeting Of Folate Receptor Alpha Positive Tumors Via Folate Receptor Selective Novel 5- And 6- Substituted Pyrrolo [2,3-D]pyrimidine Antifolates"

  2015cites this paper
• Downregulation of human epidermal growth factor receptor 2 by short hairpin RNA increases chemosensitivity of human ovarian cancer cells.

  2015cites this paper
• Tissue Factor–Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes

  2015cites this paper
• Rab25 is responsible for phosphoinositide 3-kinase/AKT‑mediated cisplatin resistance in human epithelial ovarian cancer cells.

  2015cites this paper
• Rab 25 is responsible for phosphoinositide 3-kinase / AKT-mediated cisplatin resistance in human epithelial ovarian cancer cells

  2014cites this paper
• p53 protein aggregation promotes platinum resistance in ovarian cancer

  2014cites this paper
• Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.

  2014cites this paper
• A multiscale road map of cancer spheroids – incorporating experimental and mathematical modelling to understand cancer progression

  2013cites this paper
• Rsf‐1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development

  2013cites this paper
• Expression of Folate Receptor-&agr; (FRA) in Gynecologic Malignancies and its Relationship to the Tumor Type

  2013cites this paper
• Transcription Factor-MicroRNA-Target Gene Networks Associated with Ovarian Cancer Survival and Recurrence

  2013cites this paper
• Two-tier system on the origin of epithelial ovarian carcinomas and associated molecular biological basis

  2013cites this paper
• Multiparameter flow cytometric immunophenotyping of epithelial cells in effusions. Technical improvements and apoptosis measurement.

  2013cites this paper
• Molecular Pathology of Ovarian Cancer

  2013cites this paper
• Identification and characterization of gene and microRNA networks associated with cancer survival and drug abuse

  2013cites this paper
• Wybrane czynniki molekularne związane z przerzutowaniem raka jajnika

  2012cites this paper
• ABSTRACT Title of Thesis: METHYLSELENINIC ACID SENSITIZES NOTCH 3- ACTIVATED OVCA429 OVARIAN CANCER CELLS TO CARBOPLATIN

  2012cites this paper
• DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin

  2012cites this paper
• ATP-dependent chromatin remodeling in the DNA-damage response

  2012cites this paper
• Activin and inhibin, estrogens and NFκB, play roles in ovarian tumourigenesis is there crosstalk?

  2012cites this paper
• Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells.

  2012cites this paper
• Pathway crosstalk analysis based on protein-protein network analysis in ovarian cancer.

  2012cites this paper
• Knockdown of mediator complex subunit 19 inhibits the growth of ovarian cancer.

  2012cites this paper
• Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways

  2012cites this paper
• Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells

  2012cites this paper
• RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis.

  2012influential citation
• MKK4 acts as a potential tumor suppressor in ovarian cancer

  2011cites this paper
• Knockdown of stat3 expression by RNAi inhibits in vitro growth of human ovarian cancer

  2011cites this paper
• Variants in folate pathway genes as modulators of genetic instability and lung cancer risk

  2011cites this paper
• Perinatal exposure to low-dose DE-71 increases serum thyroid hormones and gonadal osteopontin gene expression

  2011cites this paper
• Rsf-1 (HBXAP) Expression is Associated With Advanced Stage and Lymph Node Metastasis in Ovarian Clear Cell Carcinoma

  2011cites this paper
• Folate Receptors and Therapeutic Applications

  2011cites this paper
• Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome.

  2011cites this paper
• MUC4 gene polymorphisms associate with endometriosis development and endometriosis-related infertility

  2011cites this paper
• Searching for a system: The quest for ovarian cancer biomarkers

  2010cites this paper
• Analysis of chemotherapeutic response heterogeneity and drug clustering based on mechanism of action using an in vitro assay.

  2010cites this paper
• New determinates of disease progression and outcome in metastatic ovarian carcinoma.

  2010cites this paper